Monoclonal Antibody-Based Therapy for Eosinophilic Oesophagitis

Monoclonal Antibody-Based Therapy for Eosinophilic Oesophagitis

December 1, 2016 at 8:19 AM 0 comments

*Garry M. Walsh School of Medicine, Medical Sciences and Nutrition, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK *Correspondence to g.m.walsh@abdn.ac.uk Disclosure: The author has declared no conflicts of interest. Received: 23.06.16 Accepted: 25.08.16 Citation: EMJ Gastroenterol. 2016;5[1]:125-129. Abstract Eosinophilic oesophagitis is an inflammatory condition associated with marked eosinophilRead More

How to Improve Your Success in Treating Mild and Moderate Inflammatory Bowel Disease

How to Improve Your Success in Treating Mild and Moderate Inflammatory Bowel Disease

May 12, 2016 at 8:30 AM 0 comments

Summary of presentations from the Tillotts Pharma-sponsored Satellite Symposium on Inflammatory Bowel Disease, held in Amsterdam, Netherlands, on 18th March 2016 Chairperson: Geert D’Haens1 Speakers: Ailsa Hart,2 Pieter Hindryckx3 1. Academic Medical Centre-IBD Unit, University of Amsterdam, Amsterdam, Netherlands 2. Director, IBD Unit, St Mark’s Hospital, London, UK 3. ResearchRead More

Beyond the Gut: The Importance of Controlling Systemic Inflammation in Inflammatory Bowel Disease

Beyond the Gut: The Importance of Controlling Systemic Inflammation in Inflammatory Bowel Disease

May 6, 2016 at 8:30 AM 0 comments

Summary of presentations from the AbbVie-Sponsored Symposium on Inflammatory Bowel Disease, held at the 11th Congress of the European Crohn’s and Colitis Organisation (ECCO) in Amsterdam, Netherlands, on 17th March 2016 Chairperson: Geert D’Haens1 Speakers: Yehuda Chowers,2 Remo Panaccione,3 Geert D’Haens1 1. Academic Medical Centre-IBD Unit, University of Amsterdam, Amsterdam,Read More

In It for the Long Haul: Managing the Complexity of Crohn’s Disease

In It for the Long Haul: Managing the Complexity of Crohn’s Disease

April 29, 2016 at 9:10 AM 0 comments

Summary of presentations from the Takeda-Sponsored Symposium held on at the 11th Congress of the European Crohn’s and Colitis Organisation (ECCO) in Amsterdam, Netherlands, on 18th March 2016 Chairperson: Michael A. Kamm1 Speakers: Michael A. Kamm,1 Remo Panaccione,2 Stefan Schreiber3 1. St Vincent’s Hospital, Melbourne, Australia 2. Inflammatory Bowel Disease Group, UniversityRead More

Management of Ulcerative Colitis: Putting Patients at the Centre

Management of Ulcerative Colitis: Putting Patients at the Centre

April 29, 2016 at 9:03 AM 0 comments

Summary of presentations from the Takeda-sponsored symposium at the 11th Congress of the European Crohn’s and Colitis Organisation, held in Amsterdam, Netherlands on 18th March 2016 Chairperson: Iris Dotan1 Speakers: Peter Irving,2 David T. Rubin3 1. Tel Aviv Sourasky Medical Center and the Sackler School of Medicine, Tel Aviv, Israel 2. Guy’s and StRead More

Regorafenib in Advanced and Refractory Gastrointestinal Cancers

Regorafenib in Advanced and Refractory Gastrointestinal Cancers

April 5, 2016 at 8:57 AM 0 comments

*Ewen D. Legg Halcyon Medical Writing LTD., Thurso, UK *Correspondence to ewen.d.legg@gmail.com Disclosure: Medical writing assistance was funded by Bayer. Received: 08.02.16 Accepted: 09.03.16 Citation: EMJ. 2016;1[2]:18-25. Abstract The American Society of Clinical Oncology’s 2016 Gastrointestinal Cancer Symposium (ASCO-GI), held in San Francisco, California, USA, provided a forum for leadingRead More

Achieving Treatment Goals in Inflammatory Bowel Disease: The Role of Gut-Selective Therapy

Achieving Treatment Goals in Inflammatory Bowel Disease: The Role of Gut-Selective Therapy

December 15, 2015 at 9:34 AM 0 comments

Summary of presentations from the Takeda-sponsored symposia held at the 23rd United European Gastroenterology Week in Barcelona, Spain, on 26th and 28th October 2015 Gut-Selective Biologic Therapy for Ulcerative Colitis: Lessons from Science and Practice Chairperson: Gert Van Assche1 Speakers: Axel U. Dignass,2 Britta Siegmund,3 William J. Sandborn4 Management ofRead More

Biologic Therapies: From Complexity to Clinical Practice in a Changing Environment

Biologic Therapies: From Complexity to Clinical Practice in a Changing Environment

December 15, 2015 at 9:32 AM 0 comments

This symposium took place on 27th October 2015 as part of the United European Gastroenterology (UEG) Week 2015 in Barcelona, Spain Chairperson Remo Panaccione1 Speakers Remo Panaccione,1 Geert D’Haens,2 Brian Feagan3 1. Department of Medicine, University of Calgary, Calgary, Alberta, Canada 2. Inflammatory Bowel Disease Center, Academic Medical Center, Amsterdam,Read More

The Full Picture of Ulcerative Colitis: The Burden, the Patient, the Treatment

The Full Picture of Ulcerative Colitis: The Burden, the Patient, the Treatment

December 15, 2015 at 9:30 AM 0 comments

This symposium took place on 26th October 2015 as part of United European Gastroenterology (UEG) Week 2015 in Barcelona, Spain Chairperson Julián Panés1,2 Speakers Edouard Louis,3 Paul Rutgeerts4 1. Department of Medicine, University of Barcelona, Barcelona, Spain 2. International Clinical Observation Programs in the Inflammatory Bowel Diseases Unit, Hospital ClínicRead More

Gut Microbiota: Modulate its Complexity to Restore the Balance

Gut Microbiota: Modulate its Complexity to Restore the Balance

December 15, 2015 at 9:29 AM 0 comments

This symposium took place on 26th October 2015 as part of the 23rd United European Gastroenterology Week in Barcelona, Spain Chairperson Fermín Mearin1 Speakers Fermín Mearin,1 Antonio Gasbarrini,2 Peter Malfertheiner,3 Mark Pimentel4 1. Centro Médico Teknon, Barcelona, Spain 2. Gemelli University Hospital, Catholic University of Rome, Rome, Italy 3. OttoRead More